Is CyberArk Stock a Buy, Sell or Hold?
CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…
Buy
76
ADMA Quote, Financials, Valuation and Earnings
Last price:
$19.80
Seasonality move
:
18.35%
Day range:
$19.17 - $19.82
52-week range:
$5.90 - $23.64
Dividend yield:
0%
P/E ratio:
24.15x
P/S ratio:
11.28x
P/B ratio:
13.48x
Volume:
8.6M
Avg. volume:
3M
1-year change:
219.87%
Market cap:
$4.7B
Revenue:
$426.5M
EPS (TTM):
$0.82
Earnings Data
Next earnings date for ADMA
May 09
2025
Most recent earnings per share
$0.46
Beat by $0.31
(Mar 3/2025)
Consensus Estimate
$0.15
(Mar 3/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ADMA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/09/2025 | Q1 | $116.4M | -- | -- | $0.14 | -- |
| 03/03/2025 | Q4 | $112.8M | $117.5M | $0.46 | $0.15 | $0.31 |
| 11/07/2024 | Q3 | $105.9M | $119.8M | $0.15 | $0.13 | $0.02 |
| 08/08/2024 | Q2 | $86.4M | $107.2M | $0.13 | $0.08 | $0.05 |
| 05/09/2024 | Q1 | $77.3M | $81.9M | $0.08 | $0.05 | $0.03 |
| 02/28/2024 | Q4 | $73M | $73.9M | -$0.08 | $0.02 | -$0.10 |
| 11/08/2023 | Q3 | -- | -- | $0.01 | -$0.01 | $0.02 |
| 08/09/2023 | Q2 | -- | -- | -$0.03 | -$0.03 | -$0.00 |
| 05/10/2023 | Q1 | -- | -- | -$0.03 | -$0.04 | $0.01 |
| 03/23/2023 | Q4 | -- | -- | -$0.06 | -$0.07 | $0.01 |
| 11/09/2022 | Q3 | -- | -- | -$0.08 | -$0.07 | -$0.01 |
| 08/10/2022 | Q2 | -- | -- | -$0.07 | -$0.08 | $0.01 |
| 05/11/2022 | Q1 | -- | -- | -$0.13 | -$0.08 | -$0.05 |
| 03/24/2022 | Q4 | -- | -- | -$0.09 | -$0.09 | $0.00 |
| 11/10/2021 | Q3 | -- | -- | -$0.13 | -$0.14 | $0.01 |
| 08/11/2021 | Q2 | -- | -- | -$0.15 | -$0.16 | $0.01 |
| 05/12/2021 | Q1 | -- | -- | -$0.16 | -$0.17 | $0.01 |
| 03/25/2021 | Q4 | -- | -- | -$0.20 | -- | -- |
| 11/05/2020 | Q3 | -- | -- | -$0.19 | -- | -- |
| 08/05/2020 | Q2 | -- | -- | -$0.23 | -- | -- |
| 05/06/2020 | Q1 | -- | -- | -$0.26 | -- | -- |
| 03/12/2020 | Q4 | -- | -- | -$0.18 | -- | -- |
| 11/06/2019 | Q3 | -- | -- | -$0.19 | -- | -- |
| 08/08/2019 | Q2 | -- | -- | -$0.25 | -- | -- |
| 05/08/2019 | Q1 | -- | -- | -$0.28 | -- | -- |
| 03/13/2019 | Q4 | -- | -- | -$0.39 | -- | -- |
| 11/08/2018 | Q3 | -- | -- | -$0.33 | -- | -- |
| 08/10/2018 | Q2 | -- | -- | -$0.35 | -- | -- |
| 05/14/2018 | Q1 | -- | -- | -$0.39 | -- | -- |
| 03/05/2018 | Q4 | -- | -- | -$0.29 | -- | -- |
| 11/03/2017 | Q3 | -- | -- | -$0.59 | -- | -- |
| 08/11/2017 | Q2 | -- | -- | -$0.55 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$0.51 | -- | -- |
| 02/24/2017 | Q4 | -- | -- | -$0.35 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$0.34 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$0.50 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$0.43 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -$0.45 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$0.48 | -- | -- |
| 06/30/2015 | Q2 | -- | -- | -$0.44 | -- | -- |
| 03/31/2015 | Q1 | -- | -- | -$0.37 | -- | -- |
ADMA Biologics Earnings Questions
-
How Much did ADMA Biologics Generate in Revenue Last Quarter?
ADMA Biologics reported $117.5M worth of top line sales in its most recent quarter.
-
Did ADMA Biologics Beat Earnings Last Quarter?
ADMA Biologics announced earnings per share of $0.46 which represents a beat of analyst forecast a $0.15 per share.
-
Is ADMA Biologics Profitable?
ADMA Biologics reported $63.3M that represents $0.26 per share over the last quarter.
-
What is the Analyst Consensus for ADMA Biologics EPS Next Year?
ADMA Biologics's earnings are forecast to decrease from $0.81 per share to $0.71 per share next year representing a decrease of -12.35%.
-
When is ADMA Biologics's Earnings Date?
ADMA Biologics's next earnings date is May 9, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Amazon Stock Still Worth Staking On?
Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…
Is Palantir a Good Stock to Buy?
Palantir Technologies (PLTR) stock soared to its highest level in…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
